Piper Sandler Maintains Overweight on BXP, Lowers Price Target to $75

Benzinga Newsdesk www.benzinga.com Negative 60.7%

Neg 60.7% Neu 0% Pos 0%

Piper Sandler analyst Alexander Goldfarb maintains BXP (NYSE:BXP) with a Overweight and lowers the price target from $87 to $75.